Cargando…
Clinical outcomes of chondroblastoma treated using synthetic bone substitute: risk factors for developing radiographic joint degeneration
BACKGROUND: Chondroblastoma (CB) is a rare locally aggressive bone tumor that commonly occurs in the epiphysis or apophysis of long bones. Although surgical treatment of CB carries potential risk for physeal or articular cartilage damage, risk factors for joint degeneration have not been well descri...
Autores principales: | Outani, Hidetatsu, Kakunaga, Shigeki, Hamada, Kenichiro, Takenaka, Satoshi, Nakai, Sho, Yasuda, Naohiro, Imura, Yoshinori, Naka, Norifumi, Araki, Nobuhito, Ueda, Takafumi, Yoshikawa, Hideki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7053063/ https://www.ncbi.nlm.nih.gov/pubmed/32122388 http://dx.doi.org/10.1186/s12957-020-01829-4 |
Ejemplares similares
-
Reply to the letter to the editor concerning the article “clinical outcomes of chondroblastoma treated using synthetic bone substitute: risk factors for developing radiographic joint degeneration”
por: Outani, Hidetatsu, et al.
Publicado: (2021) -
Clinical Outcomes of Osteoarticular Extracorporeal Irradiated Autograft for Malignant Bone Tumor
por: Takenaka, Satoshi, et al.
Publicado: (2020) -
18F-Fluorodeoxyglucose Positron Emission Tomography Is Useful in the Evaluation of Prognosis in Retroperitoneal Sarcoma
por: Wakamatsu, Toru, et al.
Publicado: (2021) -
Therapeutic potential of TAS-115 via c-MET and PDGFRα signal inhibition for synovial sarcoma
por: Yamada, Shutaro, et al.
Publicado: (2017) -
TAS‐115 inhibits PDGFRα/AXL/FLT‐3 signaling and suppresses lung metastasis of osteosarcoma
por: Yasuda, Naohiro, et al.
Publicado: (2020)